Back to search

Article

An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancer

2024-01-19

Abstract excerpt

<title>Abstract</title> <p>Clinical efficacy of anti-PD1 immunotherapy is often with low response rates in Epstein-Barr virus-associated gastric cancer (EBVaGC). To gain insights into the immune escape and discovering the key molecule against anti-tumor immunity, we performed an immune checkpoint screening with transcriptome profiling and IHC staining data. CD276 was found as an independent immune suppressive mol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca2b2091-8359-58c3-80ef-096c88a1cb12
DOI
10.21203/rs.3.rs-3283256/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancerDOI 10.21203/rs.3.rs-3283256/v1
Select a neighboring publication to make it the new centre.